Continuous Glucose Monitoring During Diets That Differ in Glycemic Load

Glucose Metabolism Disorders Clinical Trial

— GLOW  

Official title:

Continuous Glucose Monitoring During Diets That Differ in Glycemic Load

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02926118
• Other study ID #: REF-CSC-2682
• Status: Completed
• Phase: N/A
• First received: October 5, 2016
• Last updated: October 18, 2017
• Start date: April 27, 2017
• Est. completion date: October 18, 2017

Study information

• Verified date: October 2017
• Source: Unilever R&D
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study test whether a Continuous Glucose Monitor can pickup differences in glucose (in the interstitial fluid) during a dietary intervention using meals with either a high with a low glycemic load.

Description:

The aim of this study is to determine the suitability of a continuous glucose monitor to detect the impact of a dietary intervention on postprandial blood glucose levels in normal, healthy, free living subjects. We will compare a dietary intervention of meals with a high glycemic load (high post-meal blood glucose) versus meals with a low glycemic load (low post-meal blood glucose) in a cross-over study. In addition, the glucose profiles obtained both via venous blood sampling and via continuous glucose monitor following a standard carbohydrate load will be compared.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 23
• Est. completion date: October 18, 2017
• Est. primary completion date: July 13, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years to 70 Years

Eligibility

Inclusion Criteria:

• Apparently healthy males and post-menopausal females

• Age at start of the study = 50 and = 70 years

• Body mass index (BMI) = 25.0 and = 35.0 kg/m2

• Fasting blood glucose value of subjects is = 3.4 and < 6.1 mmol/L at screening

• Being used to eat three meals a day

• Having a general practitioner

• Agreeing to be informed about medically relevant personal test-results by a physician

• Accessible veins on arms as determined by examination at screening.

Exclusion Criteria:

• Having a medical conditions which might affect the study measurements (including but not limited to: diabetes type 1 and type 2, gastrointestinal disorders, gastrointestinal surgery and inflammatory diseases, as judged by the study physician

• Reported use of over-the-counter or prescribed medication or food supplements, which may interfere with study measurements as judged by the principal investigator

• Use of oral antibiotics in 40 days or less prior to the start of the study

• Reported participation in another nutritional or biomedical study 3 months before the screening or during the study

• Reported participation in night shift work 2 weeks prior to screening or during the study. Night work is defined as working between mid-night and 6.00 am

• Reported intense sporting activities > 2h/w. Intense sporting activities are defined as those activities that cause a lack of breath which limits the ability to have a normal conversation

• Reported alcohol consumption > 10 units/week (female) or > 14 units/week (male)

• Reported use of any nicotine containing products in the 6 months preceding the study and willing to abstain from use of nicotine containing products during the study itself

• Reported dietary habits: medically prescribed diet, slimming diet, vegetarian

• Reported weight loss/gain (> 3 kg) in the last 2 months before the study

• Being an employee of Unilever or research departments in NUTRIM or the Maastricht University Medical Centre (MUMC+) collaborating in this study

• Known allergy or intolerance to food products.

• Blood donation in the past 3 months

Related Conditions & MeSH terms

• Glucose Metabolism Disorders
• Metabolic Diseases

Intervention

Dietary Supplement:
• Low glycemic load
Low glycemic load diets will be consumed at breakfast, lunch and dinner for three consecutive days
• High glycemic load
High glycemic load diets will be consumed at breakfast, lunch and dinner for three consecutive days

Locations

Country	Name	City	State
Netherlands	Maastricht University	Maastricht

Sponsors (2)

Lead Sponsor	Collaborator
Unilever R&D	Maastricht University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Carry over of the dietary intervention into the next day	Difference in glucose (in venous blood) and insulin responses to a standard meal consumed on the day after both the low and high glycemic load diets. 2-hour post prandial Incremental are under the curve for glucose and insulin in venous blood will be calculated.	0 - 120 minutes after the standard meal
Other	Carry over as measured in venous blood versus as measured during continuous glucose monitoring	Compare the difference in glucose responses to the standard meal on morning after the low and the high glycemic load diet measured in venous blood with the difference as measured in using continuous blood glucose monitor. 2-hour post prandial incremental area under the curve for glucose will be calculated for both methods.	0 - 120 minutes after the standard meal
Other	Post prandial glucose concentration during breakfast, lunch or dinner.	Difference in post prandial glucose concentrations between the low glycemic load and the high glycemic load diet. Incremental area under the curve after each of the three main meals (breakfast, lunch, dinner) during the three-day dietary interventions will be calculated separately. The three post prandial periods for both low and high glycemic load diet per subject will be combined in separate mixed models for breakfast, a model for lunch and a model for dinner.	0 - 120 minutes after each of the start of the meal
Primary	Post prandial glucose concentration	Difference in glucose concentrations between the low glycemic load and the high glycemic load diet. Incremental area under the curve after the three main meals (breakfast, lunch, dinner) during both dietary interventions will be calculated. The nine post prandial periods for both low and high glycemic load diet per subject will be combined in the mixed model.	0 - 120 minutes after the start of each of the 3 main meals (breakfast, lunch dinner)
Secondary	Three-day glucose concentration	Difference in glucose concentrations between the low and the high glycemic load diet. Total area under the curve will be compared	From start of dietary intervention until the end 3 days later
Secondary	Day time glucose concentration	Difference in glucose concentrations between the low and the high glycemic load diet. Total area under the curve will be compared	Between 07:00-22:00 h
Secondary	Night time glucose concentration	Difference in glucose concentrations between the low and the high glycemic load diet. Total area under the curve will be compared	Between 22:01-26:59 h
Secondary	Glucose variability	The Continuous Overall Net Glycemic Action (CONGA) will be calculated.	From start of dietary intervention until the end 3 days later
Secondary	Comparison of continuous interstitial glucose with venous blood glucose	Bland-Altman plots of venous blood glucose plotted against the continuous interstitial glucose at the closest available time point. Standard meal will be 200 grams of rice consumed on the day after both the low and high glycemic load diets	-30, -15, 15, 30, 45, 60, 90 and 120 minutes after consumption of a standard meal